Julia Elena Marquez-Arrico
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julia Elena Marquez-Arrico has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Ana Adan
Universitat de Barcelona
15 shared publications - José Francisco Navarro
Department of Psychobiology, School of Psychology, University of Málaga, Spain
6 shared publications Gemma Prat
Department of Clinical Psychology and Psychobiology, School of Psychology, University of Barcelona, Passeig de la Vall d'Hebron, 171, 08035 Barcelona, Spain
3 shared publications- Gail Gilchrist
National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience King's College London London UK
2 shared publications - Gemma Prat
Department of Clinical Psychology and Psychobiology, School of Psychology, University of Barcelona, Passeig de la Vall d’Hebrón 171, 08035 Barcelona, Spain
2 shared publications José Francisco Navarro
Department of Clinical Psychology and Psychobiology, School of Psychology, University of Barcelona, Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Springer Nature in International Journal of Mental Health and Addiction
Barriers to Access and Gender-Specific Treatment Needs Among Women with Substance Use Disorders: A Systematic Review with a Gender Perspective
Women with substance use disorders (SUD) face persistent inequities in access to and engagement with treatment, shaped by the intersection of gender, trauma, and structural conditions. This systematic review synthesizes empirical evidence on barriers to treatment access among women with SUD and identifies key components of gender-responsive and trauma-informed interventions. Following PRISMA 2020 guidelines, systematic searches were conducted in Web of Science, PubMed, and Scopus for empirical studies published from 1 January 2015 to 31 December 2025. Fifteen empirical studies conducted in Western contexts met inclusion criteria. Data were extracted using a PICO framework, synthesized through thematic and structured narrative synthesis, and appraised using design-specific CASP checklists. Four interrelated barrier domains were identified: structural, sociocultural, normative, and emotional. Facilitating factors included trauma-informed care, integrated and flexible services, mother–child programs, and empathetic therapeutic relationships, which were reported as supporting engagement, perceived safety, and continuity of care. Barriers to addiction treatment for women are systemic rather than individual, underscoring the need for gender-responsive and trauma-informed models to achieve equitable and effective care.
- 3 July 2026
- Published by Springer Nature in International Journal of Mental Health and Addiction
Open AccessBarriers to Access and Gender-Specific Treatment Needs Among Women with Substance Use Disorders: A Systematic Review with a Gender Perspective
Women with substance use disorders (SUD) face persistent inequities in access to and engagement with treatment, shaped by the intersection of gender, trauma, and structural conditions. This systematic review synthesizes empirical evidence on barriers to treatment access among women with SUD and identifies key components of gender-responsive and trauma-informed interventions. Following PRISMA 2020 guidelines, systematic searches were conducted in Web of Science, PubMed, and Scopus for empirical studies published from 1 January 2015 to 31 December 2025. Fifteen empirical studies conducted in Western contexts met inclusion criteria. Data were extracted using a PICO framework, synthesized through thematic and structured narrative synthesis, and appraised using design-specific CASP checklists. Four interrelated barrier domains were identified: structural, sociocultural, normative, and emotional. Facilitating factors included trauma-informed care, integrated and flexible services, mother–child programs, and empathetic therapeutic relationships, which were reported as supporting engagement, perceived safety, and continuity of care. Barriers to addiction treatment for women are systemic rather than individual, underscoring the need for gender-responsive and trauma-informed models to achieve equitable and effective care.
- Open Access
- 14 April 2026
- Published by Springer Nature in Current Addiction Reports
- Vol. 13 (1)
Circadian Rhythm and Substance Use in Adults: A Scoping Review of Sex-Based Differences
Purpose of Review: Circadian rhythms regulate sleep–wake cycles and other biological and behavioral processes, and are known to interact bidirectionally with substance use and substance use disorders (SUD). Emerging evidence suggests these interactions being modulated by sex-based biological and psychosocial factors, yet the research from a sex-specific perspective remains limited. This review analyzes and synthesizes the existing evidence on sex-related differences in circadian rhythm among adults with substance use and SUD. Recent Findings: Following the PRISMA-ScR framework, we searched seven databases for primary studies published in the last decade reporting circadian parameters (e.g., sleep quality, chronotype) with sex-related outcomes in adults with substance use/SUD. Twenty-three eligible studies were selected, and data were extracted and synthesized narratively. Women consistently exhibited poorer sleep quality, higher insomnia symptoms, and stronger associations between substance use (especially alcohol and cannabis) and circadian disruption. Despite these patterns, most studies treated sex as a secondary variable or predictor, and objective circadian measures (e.g., actigraphy, melatonin) were rarely employed. Circadian differences were also evident, with evening preference linked to greater SUD risk in men, while social jetlag was more strongly associated with alcohol misuse in women. Summary: Sex differences are reported in sleep and circadian characteristics among people with substance use/SUD, with women exhibiting greater problems. Current research is mainly considering sex as a secondary variable and there is a lack of sex-stratified data, which might be masking sex-based differences and leading to inaccurate conclusions about efficacy, safety of treatments, or risk factors. A gender-informed approach is essential for advancing in prevention and treatment strategies.
- 14 April 2026
- Published by Springer Nature in Current Addiction Reports
- Vol. 13 (1)
Open AccessCircadian Rhythm and Substance Use in Adults: A Scoping Review of Sex-Based Differences
Purpose of Review: Circadian rhythms regulate sleep–wake cycles and other biological and behavioral processes, and are known to interact bidirectionally with substance use and substance use disorders (SUD). Emerging evidence suggests these interactions being modulated by sex-based biological and psychosocial factors, yet the research from a sex-specific perspective remains limited. This review analyzes and synthesizes the existing evidence on sex-related differences in circadian rhythm among adults with substance use and SUD. Recent Findings: Following the PRISMA-ScR framework, we searched seven databases for primary studies published in the last decade reporting circadian parameters (e.g., sleep quality, chronotype) with sex-related outcomes in adults with substance use/SUD. Twenty-three eligible studies were selected, and data were extracted and synthesized narratively. Women consistently exhibited poorer sleep quality, higher insomnia symptoms, and stronger associations between substance use (especially alcohol and cannabis) and circadian disruption. Despite these patterns, most studies treated sex as a secondary variable or predictor, and objective circadian measures (e.g., actigraphy, melatonin) were rarely employed. Circadian differences were also evident, with evening preference linked to greater SUD risk in men, while social jetlag was more strongly associated with alcohol misuse in women. Summary: Sex differences are reported in sleep and circadian characteristics among people with substance use/SUD, with women exhibiting greater problems. Current research is mainly considering sex as a secondary variable and there is a lack of sex-stratified data, which might be masking sex-based differences and leading to inaccurate conclusions about efficacy, safety of treatments, or risk factors. A gender-informed approach is essential for advancing in prevention and treatment strategies.
- Open Access
Could Periodontitis Increase the Risk of Suffering from Pancreatic Cancer?—A Systematic Review
(1) Background: The relationship between periodontitis and systemic pathologies continues to grow. Recently, the presence of periodontal pathogens has been linked to an increased risk of pancreatic cancer (PC) and its mortality. Thus, a systematic review is needed to identify whether an association between the two diseases can be established. The objective of this review is to elucidate the mechanisms responsible for this association. (2) Methods: A systematic review was carried out using three databases (PubMed, Embase and Scopus) with the following keywords “Periodontitis AND pancreatic cancer”. A total of 653 articles were retrieved; before selection and screening, the inclusion and exclusion criteria were defined, resulting in a total of 13 articles being included in the review. (3) Results: The increase in low-grade systemic inflammation, pH changes, and the cytotoxicity of certain periodontopathogenic bacteria were found in the scientific literature reviewed as mechanisms linking periodontitis with the risk of PC. (4) Conclusions: Through this systematic review, we have seen how periodontitis can be related to PC and how it worsens its prognosis. Knowing the behavior of periodontopathogenic bacteria and the influence they have on our immune and inflammatory system may help to achieve an interdisciplinary approach to both pathologies.
Open AccessCould Periodontitis Increase the Risk of Suffering from Pancreatic Cancer?—A Systematic Review
(1) Background: The relationship between periodontitis and systemic pathologies continues to grow. Recently, the presence of periodontal pathogens has been linked to an increased risk of pancreatic cancer (PC) and its mortality. Thus, a systematic review is needed to identify whether an association between the two diseases can be established. The objective of this review is to elucidate the mechanisms responsible for this association. (2) Methods: A systematic review was carried out using three databases (PubMed, Embase and Scopus) with the following keywords “Periodontitis AND pancreatic cancer”. A total of 653 articles were retrieved; before selection and screening, the inclusion and exclusion criteria were defined, resulting in a total of 13 articles being included in the review. (3) Results: The increase in low-grade systemic inflammation, pH changes, and the cytotoxicity of certain periodontopathogenic bacteria were found in the scientific literature reviewed as mechanisms linking periodontitis with the risk of PC. (4) Conclusions: Through this systematic review, we have seen how periodontitis can be related to PC and how it worsens its prognosis. Knowing the behavior of periodontopathogenic bacteria and the influence they have on our immune and inflammatory system may help to achieve an interdisciplinary approach to both pathologies.
- Open Access
- 13 July 2023
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 75, 41-58
Neuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: A systematic review
- 13 July 2023
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 75, 41-58
Open AccessNeuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: A systematic review
- Open Access
- 9 November 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (22) , 6648
Patients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders
Comorbidity of substance use disorders (SUD) and severe mental illness (SMI) is highly frequent in patients, the most common diagnoses being schizophrenia (SZ), bipolar disorder (BD) and major depressive disorder (MDD). Since comorbidity has its own clinical features, and neurocognitive functioning is not always similar to psychiatric symptoms the present study explores the cognitive performance of patients with dual disorders. A neuropsychological battery of tests was used to assess 120 under treatment male patients, 40 for each group considered (SZ + SUD, BD + SUD and MDD + SUD) who were mainly polyconsumers. Significant differences (with premorbid IQ as a covariate) were found among the groups, with SZ + SUD having a worse performance in attention, verbal learning, short term memory and recognition. The consideration of a global Z score for performance evidenced an impaired neurocognitive pattern for SZ + SUD compared with BD + SUD and MDD + SUD. According to norms, all patients showed difficulties in verbal learning, short-term memory and recognition. Our research indicated that the neurocognitive functioning of dual disorder patients was influenced by the comorbid SMI, with SZ + SUD presenting major difficulties. Future studies should thoroughly explore the role of such difficulties as indicators or endophenotypes for dual schizophrenia disorders, and their usefulness for prevention and treatment.
- 9 November 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (22) , 6648
Open AccessPatients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders
Comorbidity of substance use disorders (SUD) and severe mental illness (SMI) is highly frequent in patients, the most common diagnoses being schizophrenia (SZ), bipolar disorder (BD) and major depressive disorder (MDD). Since comorbidity has its own clinical features, and neurocognitive functioning is not always similar to psychiatric symptoms the present study explores the cognitive performance of patients with dual disorders. A neuropsychological battery of tests was used to assess 120 under treatment male patients, 40 for each group considered (SZ + SUD, BD + SUD and MDD + SUD) who were mainly polyconsumers. Significant differences (with premorbid IQ as a covariate) were found among the groups, with SZ + SUD having a worse performance in attention, verbal learning, short term memory and recognition. The consideration of a global Z score for performance evidenced an impaired neurocognitive pattern for SZ + SUD compared with BD + SUD and MDD + SUD. According to norms, all patients showed difficulties in verbal learning, short-term memory and recognition. Our research indicated that the neurocognitive functioning of dual disorder patients was influenced by the comorbid SMI, with SZ + SUD presenting major difficulties. Future studies should thoroughly explore the role of such difficulties as indicators or endophenotypes for dual schizophrenia disorders, and their usefulness for prevention and treatment.
- Open Access
- 29 October 2021
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 12
Circadian Functioning and Quality of Life in Substance Use Disorder Patients With and Without Comorbid Major Depressive Disorder
Aim: Although a relationship between circadian disruption and development of several psychiatric disorders, such as major depressive disorder (MDD) and substance use disorder (SUD), has been observed, knowledge on this area is scarce yet. Therefore, this study aims to analyze the circadian functioning and quality of life (QOL) in SUD patients with and without comorbid MDD, two highly prevalent clinical entities with difficult therapeutic management.Methods: One hundred sixty-three male patients under treatment, 81 with SUD and 82 with SUD comorbid major depressive disorder (SUD + MDD), were evaluated. For the circadian functioning assessment, we calculated Social Jet Lag (SJL) and used the reduced Morningness–Eveningness Questionnaire (rMEQ) and the Pittsburgh Sleep Quality Index (PSQI). QOL was measured using the shortened version of the World Health Organization's Quality of Life Questionnaire (WHOQOL-BREF). We collected sociodemographic and clinical variables to evaluate their possible influence on the circadian functioning. Intergroup differences among the variables were examined by different analyses of covariance (ANCOVA and MANCOVA). The possible relationships of quantitative clinical variables with rMEQ, PSQI, and WHOQOL-BREF were explored using bivariate correlation analysis.Results: Lower SJL appears in the SUD + MDD group compared with SUD. The intermediate-type was more prevalent in the SUD group, while a higher percentage of morning-type patients was found in the SUD + MDD. Sleep quality (including latency and daytime dysfunction) was worse for SUD + MDD patients than for SUD even after controlling age and age of SUD onset variables. Last, QOL was poorer in patients with SUD + MDD and, for them, psychological health had a negative relationship with SJL and severity of depression.Conclusions: Our data support and extend previous findings indicating that SUD + MDD is associated with worse clinical characteristics, more sleep problems, and poorer QOL than SUD patients. These results underline the importance of a precise assessment of these measurements in future studies conducted in SUD patients with/without MDD comorbidity that could be considered from a therapeutic point of view.
- 29 October 2021
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 12
Open AccessCircadian Functioning and Quality of Life in Substance Use Disorder Patients With and Without Comorbid Major Depressive Disorder
Aim: Although a relationship between circadian disruption and development of several psychiatric disorders, such as major depressive disorder (MDD) and substance use disorder (SUD), has been observed, knowledge on this area is scarce yet. Therefore, this study aims to analyze the circadian functioning and quality of life (QOL) in SUD patients with and without comorbid MDD, two highly prevalent clinical entities with difficult therapeutic management.Methods: One hundred sixty-three male patients under treatment, 81 with SUD and 82 with SUD comorbid major depressive disorder (SUD + MDD), were evaluated. For the circadian functioning assessment, we calculated Social Jet Lag (SJL) and used the reduced Morningness–Eveningness Questionnaire (rMEQ) and the Pittsburgh Sleep Quality Index (PSQI). QOL was measured using the shortened version of the World Health Organization's Quality of Life Questionnaire (WHOQOL-BREF). We collected sociodemographic and clinical variables to evaluate their possible influence on the circadian functioning. Intergroup differences among the variables were examined by different analyses of covariance (ANCOVA and MANCOVA). The possible relationships of quantitative clinical variables with rMEQ, PSQI, and WHOQOL-BREF were explored using bivariate correlation analysis.Results: Lower SJL appears in the SUD + MDD group compared with SUD. The intermediate-type was more prevalent in the SUD group, while a higher percentage of morning-type patients was found in the SUD + MDD. Sleep quality (including latency and daytime dysfunction) was worse for SUD + MDD patients than for SUD even after controlling age and age of SUD onset variables. Last, QOL was poorer in patients with SUD + MDD and, for them, psychological health had a negative relationship with SJL and severity of depression.Conclusions: Our data support and extend previous findings indicating that SUD + MDD is associated with worse clinical characteristics, more sleep problems, and poorer QOL than SUD patients. These results underline the importance of a precise assessment of these measurements in future studies conducted in SUD patients with/without MDD comorbidity that could be considered from a therapeutic point of view.
- Open Access
- 25 September 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (19) , 4388
Circadian Characteristics in Patients under Treatment for Substance Use Disorders and Severe Mental Illness (Schizophrenia, Major Depression and Bipolar Disorder)
Dual disorders (substance use and mental illness comorbidity) are a condition that has been strongly associated with severe symptomatology and clinical complications. The study of circadian characteristics in patients with Severe Mental Illness or Substance Use Disorder (SUD) has shown that such variables are related with mood symptoms and worse recovery. In absence of studies about circadian characteristics in patients with dual disorders we examined a sample of 114 male participants with SUD and comorbid Schizophrenia (SZ+; n = 38), Bipolar Disorder (BD+; n = 36) and Major Depressive Disorder (MDD+; n = 40). The possible differences in the sample of patients according to their psychiatric diagnosis, circadian functioning with recordings of distal skin temperature during 48 h (Thermochron iButton®), circadian typology and sleep-wake schedules were explored. MDD+ patients were more morning-type, while SZ+ and BD+ had an intermediate-type; the morning-type was more frequent among participants under inpatient SUD treatment. SZ+ patients had the highest amount of sleeping hours, lowest arousal and highest drowsiness followed by BD+ and MDD+, respectively. These observed differences suggest that treatment for patients with dual disorders could include chronobiological strategies to help them synchronize patterns with the day-light cycle, since morning-type is associated with better outcomes and recovery.
- 25 September 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (19) , 4388
Open AccessCircadian Characteristics in Patients under Treatment for Substance Use Disorders and Severe Mental Illness (Schizophrenia, Major Depression and Bipolar Disorder)
Dual disorders (substance use and mental illness comorbidity) are a condition that has been strongly associated with severe symptomatology and clinical complications. The study of circadian characteristics in patients with Severe Mental Illness or Substance Use Disorder (SUD) has shown that such variables are related with mood symptoms and worse recovery. In absence of studies about circadian characteristics in patients with dual disorders we examined a sample of 114 male participants with SUD and comorbid Schizophrenia (SZ+; n = 38), Bipolar Disorder (BD+; n = 36) and Major Depressive Disorder (MDD+; n = 40). The possible differences in the sample of patients according to their psychiatric diagnosis, circadian functioning with recordings of distal skin temperature during 48 h (Thermochron iButton®), circadian typology and sleep-wake schedules were explored. MDD+ patients were more morning-type, while SZ+ and BD+ had an intermediate-type; the morning-type was more frequent among participants under inpatient SUD treatment. SZ+ patients had the highest amount of sleeping hours, lowest arousal and highest drowsiness followed by BD+ and MDD+, respectively. These observed differences suggest that treatment for patients with dual disorders could include chronobiological strategies to help them synchronize patterns with the day-light cycle, since morning-type is associated with better outcomes and recovery.
- Open Access
- 1 August 2021
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 110, 110310
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review
- 1 August 2021
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 110, 110310
Open AccessPremorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review
- Open Access
- 26 September 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10) , 3110
Health-Related Quality of Life in Male Patients under Treatment for Substance Use Disorders with and without Major Depressive Disorder: Influence in Clinical Course at One-Year Follow-Up
Health-related quality of life (HRQoL) assessment has interest as an indicator of degree of affectation and prognosis in mental disorders. HRQoL is impaired in both Substance Use Disorder (SUD) and Major Depressive Disorder (MDD), two conditions highly prevalent, although less studied when both are coexisting (SUD + MDD). Hence, we decided to explore HRQoL with the SF-36 survey in a sample of 123 SUD and 114 SUD + MDD patients (51 symptomatic and 63 asymptomatic of depressive symptoms) under treatment. We performed analyses to examine HRQoL among groups, and its predictive value at 3-, 6- and 12-month follow-ups through regression models. Patients with SUD + MDD had worse HRQoL than SUD patients and population norms. For Mental Health, Vitality, and General Health dimensions, lower scores were observed for SUD + MDD regardless the presence/absence of depressive symptoms. For Physical Functioning and Health Change, depressive symptomatology and not the comorbidity of SUD + MDD diagnoses explained HRQoL limitations. At 3-, 6- and 12-month follow-ups we observed two predictors of relapses, General Health for asymptomatic SUD + MDD, and Physical Functioning for SUD. Improving HRQoL in SUD + MDD may be targeted during patient’s treatment; future studies should explore the influence of HRQoL on patient’s prognosis taking into account the presence/absence of depressive symptomatology.
- 26 September 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10) , 3110
Open AccessHealth-Related Quality of Life in Male Patients under Treatment for Substance Use Disorders with and without Major Depressive Disorder: Influence in Clinical Course at One-Year Follow-Up
Health-related quality of life (HRQoL) assessment has interest as an indicator of degree of affectation and prognosis in mental disorders. HRQoL is impaired in both Substance Use Disorder (SUD) and Major Depressive Disorder (MDD), two conditions highly prevalent, although less studied when both are coexisting (SUD + MDD). Hence, we decided to explore HRQoL with the SF-36 survey in a sample of 123 SUD and 114 SUD + MDD patients (51 symptomatic and 63 asymptomatic of depressive symptoms) under treatment. We performed analyses to examine HRQoL among groups, and its predictive value at 3-, 6- and 12-month follow-ups through regression models. Patients with SUD + MDD had worse HRQoL than SUD patients and population norms. For Mental Health, Vitality, and General Health dimensions, lower scores were observed for SUD + MDD regardless the presence/absence of depressive symptoms. For Physical Functioning and Health Change, depressive symptomatology and not the comorbidity of SUD + MDD diagnoses explained HRQoL limitations. At 3-, 6- and 12-month follow-ups we observed two predictors of relapses, General Health for asymptomatic SUD + MDD, and Physical Functioning for SUD. Improving HRQoL in SUD + MDD may be targeted during patient’s treatment; future studies should explore the influence of HRQoL on patient’s prognosis taking into account the presence/absence of depressive symptomatology.
- Open Access
- 16 June 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (6) , 1876
Temperament and Character Profile and Its Clinical Correlates in Male Patients with Dual Schizophrenia
Personality traits are relevant in understanding substance use disorders (SUD) and schizophrenia (SZ), but few works have also included patients with dual schizophrenia (SZ+) and personality traits. We explored personality profile in a sample of 165 male patients under treatment, using the Temperament and Character Inventory-Revised. The participants were assigned to three groups of 55 patients each, according to previous diagnosis: SUD, SZ- and SZ+ (without/with SUD). We analyzed their clinical characteristics, relating them to personality dimensions. The SUD and SZ+ groups scored higher than SZ- in Novelty/Sensation Seeking. SZ- and SZ+ presented higher Harm Avoidance and lower Persistence than the SUD group. SZ+ patients showed the lowest levels of Self-directedness, while SZ- and SZ+ had higher scores in Self-transcendence than the SUD group. Several clinical characteristics were associated with personality dimensions depending on diagnosis, and remarkably so for psychiatric symptoms in the SZ- and SZ+ groups. The three groups had a maladaptive personality profile compared to general population. Our results point to different profiles for SUD versus SZ, while both profiles appear combined in the SZ+ group, with extreme scores in some traits. Thus, considering personality endophenotypes in SZ+ could help in designing individualized interventions for this group.
- 16 June 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (6) , 1876
Open AccessTemperament and Character Profile and Its Clinical Correlates in Male Patients with Dual Schizophrenia
Personality traits are relevant in understanding substance use disorders (SUD) and schizophrenia (SZ), but few works have also included patients with dual schizophrenia (SZ+) and personality traits. We explored personality profile in a sample of 165 male patients under treatment, using the Temperament and Character Inventory-Revised. The participants were assigned to three groups of 55 patients each, according to previous diagnosis: SUD, SZ- and SZ+ (without/with SUD). We analyzed their clinical characteristics, relating them to personality dimensions. The SUD and SZ+ groups scored higher than SZ- in Novelty/Sensation Seeking. SZ- and SZ+ presented higher Harm Avoidance and lower Persistence than the SUD group. SZ+ patients showed the lowest levels of Self-directedness, while SZ- and SZ+ had higher scores in Self-transcendence than the SUD group. Several clinical characteristics were associated with personality dimensions depending on diagnosis, and remarkably so for psychiatric symptoms in the SZ- and SZ+ groups. The three groups had a maladaptive personality profile compared to general population. Our results point to different profiles for SUD versus SZ, while both profiles appear combined in the SZ+ group, with extreme scores in some traits. Thus, considering personality endophenotypes in SZ+ could help in designing individualized interventions for this group.